Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors-Reference-Cited by-同舟云学术

Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors

Published:2009-04-08 Issue:8 Volume:256 Page:1288-1295
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Musicco Massimo,Palmer Katie,Salamone Giovanna,Lupo Federica,Perri Roberta,Mosti Serena,Spalletta Gianfranco,di Iulio Fulvia,Pettenati Carla,Cravello Luca,Caltagirone Carlo

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-009-5116-4.pdf

Reference42 articles.

1. Banks WA, Kastin AJ (1998) Differential permeability of the blood–brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19:883–889. doi: 10.1016/S0196-9781(98)00018-7

2. Beeri MS, Schmeidler J, Silverman JM et al (2008) Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71(10):750–757. doi: 10.1212/01.wnl.0000324925.95210.6d

3. Benedict C, Hallschmid M, Hatke A et al (2004) Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29:1326–1334. doi: 10.1016/j.psyneuen.2004.04.003

4. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74. doi: 10.1016/S1474-4422(05)70284-2

5. Borroni B, Archetti S, Ferrari M, Cesana BM, Padovani A (2007) Relationship of vascular risk to the progression of Alzheimer disease. Neurology 68:1083–1084. doi: 10.1212/01.wnl.0000260435.20698.77 author reply 1084

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of profiles associated with conversions between the Alzheimer’s disease stages, using a machine learning approach;Alzheimer's Research & Therapy;2024-07-26

2. Monoclonal antibodies for treating early Alzheimer disease—a commentary on recent ‘positive’ trials;Age and Ageing;2024-02-01

3. Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity;PharmacoEconomics - Open;2023-11-15

4. Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control;International Journal of Molecular Sciences;2023-03-23

5. Accumulation of network redundancy marks the early stage of Alzheimer's disease;Human Brain Mapping;2023-03-10